EPITOPE MAPPING OF MONOCLONAL ANTIBODIES AGAINST HUMAN CARBONIC ANHYDRASE XII

Aistė Imbrasaitė1, Dovilė Stravinskienė1, Aurelija Žvirblienė1

1 Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Human carbonic anhydrase XII (CA XII) is a single-pass transmembrane protein with an extracellular catalytic domain [1]. This enzyme is being recognized as a potential biomarker for different tumors [2]. Monoclonal antibodies (MAbs) are widely used as diagnostic, research and therapeutic reagents in oncology [3]. An important step in the characterization of MAbs, especially those used in therapeutic strategies, is the identification of the binding sites (epitopes) of these antibodies on their target antigens [4].

The aim of our study was to construct overlapping CA XII protein fragments to identify the epitopes of MAbs raised against recombinant CA XII.

Eight hexahistidine-fused overlapping fragments (fragment # 1 (aa 1–94), fragment # 2 (aa 41–175), fragment # 3 (aa 166–264), fragment # 4 (aa 75–264), fragment # 5 (aa 9–195), fragment # 6 (aa 17–184), fragment # 7 (aa 24–207) and fragment # 8 (aa 33–196)) of CA XII protein (Fig. 1) were constructed to identify the epitopes of MAbs raised against recombinant CA XII. All CA XII fragments were efficiently expressed in transformed E. coli cells. MAbs against CA XII were generated by hybridoma technology and characterized previously [2]. In total, 10 MAbs (1D5, 4A6, 5D2, 8C9, 9A8, 13F5, 15A4, 6G5, 14D6, 20G7) recognized the extracellular domain of CA XII protein by Western blot. Specific binding of the MAbs with the constructed CA XII fragments was observed. The accurate aa sequence of the epitope recognized by the MAb 14D6 was determined (Fig. 1). It was shown, that the MAb 14D6 binds near the active center of CA XII, which explains the inhibitory properties of this antibody.

Figure 1
Fig. 1. Scheme of eight overlapping CA XII protein fragments and epitope of MAb 14D6.

This study provides new data on the CA XII-specific MAbs, that are promising diagnostic and therapeutic tools which can be applied for the diagnostics and therapy of various types of cancers.


[1] D.A. Whittington, A. Waheed, B. Ulmasov, et al., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells, Proceedings of the National Academy of Sciences of the United States of America 98 (17), 9545-9550 (2001).

[2] D. Dekaminaviciute, R. Lasickiene, S. Parkkila, et al., Development and Characterization of New Monoclonal Antibodies against Human Recombinant CA XII, BioMed Research International, (2014).

[3] Q. Zhang, G. Chen, X. Liu and Q. Qian, Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy, Cell Research 17, 89–99 (2007).

[4] P. N. Nelson, G. M. Reynolds, E. E. Waldron EE, et al., Demystified …: Monoclonal antibodies, Molecular Pathology 53 (3), 111-117 (2000).